The WaldenstromÂ’s Macroglobulinemia program at the Dana-Farber Cancer Institute, a Harvard Medical School affiliate, has spearheaded national and international ...
Bio-Quant is a Biotechnology company that develops new cutting edge multiplex technologies for biomolecular screening. Providing High Quality Research and ...